Cancer Breast Cancer Living With Antidepressant Use and Breast Cancer By Anna Giorgi Anna Giorgi Anna Giorgi is a health and lifestyle writer who specializes in providing straightforward and accurate healthcare communications for consumers. Learn about our editorial process Published on November 15, 2022 Medically reviewed by Alex Yampolsky, PharmD Medically reviewed by Alex Yampolsky, PharmD LinkedIn Alex Yampolsky, PharmD, is a clinical pharmacist at Elizabeth Seton Children’s Center, a pediatric long-term care facility in Yonkers, New York. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Risk Factor Interactions Benefits Alternatives Frequently Asked Questions Depression is common among breast cancer patients. The shock of a diagnosis, the side effects of treatment, and the stress of an unknown outcome can lead to depression or anxiety. Research has shown that almost half of the 2.4 million breast cancer survivors in the United States take antidepressants to manage their mental health. Though these drugs can help people manage the mental health aspects of having breast cancer, they can also pose a threat. Studies have shown the possible negative interactions between certain antidepressants and tamoxifen, a drug that treats all stages of breast cancer. The drug is also used to reduce the onset of breast cancer in people at high risk for the disease. This article describes the effects of certain antidepressants on breast cancer drugs. It covers the options for antidepressants, the benefits for breast cancer patients, and how to safely take breast cancer drugs and antidepressants. Grace Cary / Getty Images Antidepressants: A Breast Cancer Risk Factor? Animal studies have suggested that both selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) could increase the overall risk of breast cancer and promote tumor growth. However, a meta-analysis of the connection between antidepressant use and the risk of breast cancer in humans did not identify an increase in breast cancer diagnoses among people who used either type of antidepressant. The link between antidepressants and breast cancer in humans has been seen in people who take tamoxifen. Tamoxifen works by blocking estrogen from connecting to cancer cells and promoting their growth in hormone receptor-positive breast cancers. These cancers need estrogen and/or progesterone to grow. Since tamoxifen also works like estrogen in other tissues (such as the bones and uterus), it is called a selective estrogen receptor modulator (SERM) and is a type of hormone therapy. The effects of the drug may last up to 20 years after you stop taking it. To be effective, tamoxifen must be metabolized by the liver enzyme CYP2D6. Some antidepressants can interfere with this process and reduce the effectiveness of the drug when it's used as cancer therapy or as a preventive measure. Tamoxifen for Breast Cancer Recurrence Prevention Taking Breast Cancer Medication and Antidepressants In a large population-based study that included almost 17,000 people with breast cancer, 30.6% reported taking at least one antidepressant while they were taking tamoxifen. Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are considered the first-line pharmacotherapy for depression. They are the most commonly prescribed antidepressants because of their safety, tolerability, and efficacy. However, some SSRIs and other antidepressants can interfere with the action of the CPY2D6 enzyme that is required to activate tamoxifen. While you can safely take tamoxifen and some antidepressants together, there are certain ones that you should avoid. The following antidepressants are known to be strong inhibitors of the CPY2D6 enzyme and may interfere with the effectiveness of tamoxifen: Prozac (fluoxetine) Paxil (paroxetine) Wellbutrin (bupropion) You should also avoid antidepressants that are known to be moderate inhibitors of the CYP2D6 enzyme, including: Cymbalta (duloxetine) Celexa (citalopram) Lexapro (escitalopram) Sinequan (doxepin) Tamoxifen Drug Interactions Benefits for People With Breast Cancer Protecting the benefits of tamoxifen is key for people with breast cancer. The drug has been used for 40 years with success for the following purposes: To reduce the risk of breast cancer before it develops for people who have a higher-than-average risk of the diseaseTo treat people diagnosed with advanced-stage, hormone receptor-positive breast cancerTo help extend longevity and prevent the risk of recurrence for people who have not yet gone through menopause and who have had surgery for hormone receptor-positive, early-stage breast cancerTo reduce the risk of invasive breast cancer in people diagnosed with hormone receptor-positive DCIS (ductal carcinoma in situ) after surgery While tamoxifen is key for treating the physical aspects of breast cancer, antidepressants have an important role in managing the mental health aspects of going through treatment. Antidepressants can also be effective as a non-hormonal option for treating certain menopausal-like symptoms that can occur with tamoxifen treatment. These symptoms can happen due to the drug's estrogen-blocking properties, which cause low estrogen. The most common side effects of tamoxifen include: Hot flashes Vaginal dryness or discharge Disruption of the normal menstrual cycle Over 25% of people who experience hot flashes while being treated with tamoxifen use antidepressants to control their symptoms so they can continue using the anti-cancer medication. However, not all antidepressants are as effective at treating these symptoms. For example, the drug Wellbutrin (bupropion) may not be best for treating hot flashes. According to a double-blind randomized study, the drug did not show a statistically significant reduction in the number of hot flashes between the breast cancer survivors who took it and the people who took a placebo. Hot Flashes May Be a Silver Lining of Breast Cancer Treatment Antidepressant Alternatives While certain antidepressants cannot be combined with tamoxifen treatment, there are many other options for treating depression and anxiety. Your healthcare provider can determine which drugs will be most effective and least risky. You might be able to use certain antidepressants that are considered weak inhibitors of the CPY2D6 enzyme. These drugs are not restricted by treatment with tamoxifen: Effexor XR (venlafaxine) Pristiq (desvenlafaxine) Trintellix (vortioxetine) Viibryd (vilazodone) Fetzima (levomilnacipran) Depending on your depression symptoms, you may want to talk to your provider about natural depression remedies as an alternative to drug therapy. Ask your healthcare provider before using any medications or supplements, even over-the-counter (OTC) products, to make sure they will not interfere with your breast cancer treatment. Natural alternatives to antidepressants can include: St. John's wort: Also known as Hypericum perfornatum, St. John's wort is an herb derived from a flowering plant. St. John's wart should not be taken with tamoxifen. Omega-3 fatty acids: These essential fatty acids must be consumed through your diet because your body cannot produce them naturally. They are commonly found in foods like fish and nuts and can be consumed through fish oil supplements. SAMe: Also known as S-adenosylmethionine or ademetionine, SAMe is the synthetic form of a compound that is made naturally in the body from methionine (an essential amino acid) and adenosine triphosphate (an energy-producing compound). Folic acid: This is a synthetic form of folate, the natural form of vitamin B9. Since your body does not store folate, you must replenish your supply by eating foods that are rich sources of folate like dark green vegetables, beans, and legumes. You can also take folic acid supplements. 5-Hydroxytryptophan: Also called 5-HTP, this is an amino acid that your body makes naturally. Consuming 5-HTP through supplements is more effective than trying to consume the substance through dietary sources. Nutritious diet: A balanced diet that includes less sugar, limited alcohol, and recommended amounts of vitamin B6 and magnesium may help reduce the severity of mood swings and depression. Consuming plenty of fruits, vegetables, and fiber is also linked to a reduced risk of depression. Exercise: You might be able to lower your risk of depression through exercise. The results of one study showed that people might be able to achieve these benefits with relatively small doses of movement, starting with activities equivalent to 1.25 hours of brisk walking per week. Light therapy: Getting enough sunlight can help offset depression, especially if you are also sensitive to mood changes that occur during the winter when the days are shorter. If you can't get exposure to natural sunlight during the day, consider trying light box therapy, which can provide the benefits of light indoors. Reaching Out for Support Depression is common in people coping with breast cancer but it's treatable. Talk to your provider if you have symptoms of depression like persistent feelings of sadness or hopelessness; trouble sleeping, irritability, an inability to concentrate, or lack of interest or pleasure in activities that you used to enjoy. Summary The risk of depression is over five times higher in people with cancer than in people without the disease. Dealing with the shock of having breast cancer, the side effects of treatment, and the stress of an unknown outcome can lead to mental health conditions like depression. Almost 50% of people with breast cancer use antidepressants to help cope with their symptoms. While these drugs can help you manage the mental health aspects of having breast cancer, they may also inhibit the effects of certain cancer-fighting drugs. Some antidepressants can prevent you from getting the full benefits of the drugs you are taking for breast cancer treatment. If you have breast cancer, talk to your provider about the best treatment options for you to manage your cancer and mental health diagnoses. A Word From Verywell Breast cancer can be a devastating diagnosis. It's normal to feel nervous and worried about having treatment and your future at any stage of the process. However, if you notice that you're frequently feeling sad, uninterested in your normal activities, and unable to sleep, these can be symptoms of depression. It's important to discuss your feelings with your healthcare provider if you feel overwhelmed by these emotions. Protecting your mental health is an important aspect of helping your body stay strong during all stages of cancer treatment—especially if you're taking a long-term drug like tamoxifen, which can require five to 10 years of treatment. Depression and breast cancer are two serious diagnoses on their own, but getting the right combination of treatments can help you achieve the best outcomes with both. Frequently Asked Questions Which antidepressant brands are linked to breast cancer? Research has suggested there is a possible relationship between certain antidepressants and the reduced effectiveness of tamoxifen and an increased risk of breast cancer death.The association is believed to be highest among drugs that are strong inhibitors of the CPY2D6 enzyme like Paxil (paroxetine), Prozac (fluoxetine), Wellbutrin (bupropion), and Cymbalta (duloxetine). Learn More: Antidepressants That Interact With Tamoxifen How do antidepressants influence estrogen levels? Research suggests that most antidepressants influence estrogen levels, though there is conflicting evidence about whether that effect is an increase or decrease. There is also some evidence that there is no effect.One study reported that the six most widely used SSRIs (fluoxetine, paroxetine, citalopram, escitalopram, sertraline, and fluvoxamine) were all related to decreased testosterone levels and an increase in the estrogen/androgen ratio. Learn More: What to Know About Low Estrogen Levels Which antidepressants can you take with tamoxifen? If you're taking tamoxifen, your provider will let you know which antidepressant can provide the best results without interfering with your tamoxifen therapy. Generally, the best antidepressants to take with tamoxifen are weak inhibitors of the CPY2D6 enzyme, such as venlafaxine, desvenlafaxine, vortioxetine, vilazodone, and levomilnacipran. Learn More: What to Know About SSRIs vs. SNRIs 12 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Haque R, Shi J, Schottinger JE, et al. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors. Journal of the National Cancer Institute. 2015;108(3):djv337. doi:10.1093/jnci/djv337 Busby J, Mills K, Zhang SD, et al. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study. Breast Cancer Research. 2018;20(1). doi:10.1186/s13058-017-0928-0 Eom CS, Park SM, Cho KH. Use of antidepressants and the risk of breast cancer: a meta-analysis. Breast Cancer Research and Treatment. 2012;136(3):635-646. doi:10.1007/s10549-012-2307-y The MGH Center for Women's Mental Health. Clinical update 2019: tamoxifen and antidepressants. American Cancer Society. Hormone therapy for breast cancer. Breastcancer.org. Tamoxifen. Ljungberg T, Bondza E, Lethin C. Evidence of the importance of dietary habits regarding depressive symptoms and depression. Int J Environ Res Public Health. 2020;17(5):1616. doi:10.3390/ijerph17051616 Pearce M, Garcia L, Abbas A, et al. Association between physical activity and risk of depression: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79(6):550-559. doi:10.1001/jamapsychiatry.2022.0609 National Institute of Mental Health. Depression. Hartung TJ, Brähler E, Faller H, et al. The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer. 2017;72:46-53. doi:10.1016/j.ejca.2016.11.017 Pavlidi P, Kokras N, Dalla C. Antidepressants' effects on testosterone and estrogens: What do we know? Eur J Pharmacol. 2021 May 15;899:173998. doi: 10.1016/j.ejphar.2021.173998 Hansen CH, Larsen LW, Sørensen AM, Halling-Sørensen B, Styrishave B. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line. Toxicol In Vitro. 2017 Jun;41:1-11. doi: 10.1016/j.tiv.2017.02.001 By Anna Giorgi Anna Zernone Giorgi is a writer who specializes in health and lifestyle topics. Her experience includes over 25 years of writing on health and wellness-related subjects for consumers and medical professionals, in addition to holding positions in healthcare communications. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit